Tangible Book Value
Tangible book value is a measure of a company's net asset value that excludes intangible assets such as goodwill, patents, and trademarks, reflecting only the physical and financial assets that could be liquidated or transferred to another owner in a sale or liquidation scenario. It is most commonly used in valuing financial institutions and asset-heavy businesses.
Tangible book value is calculated by subtracting intangible assets and goodwill from total shareholders equity as reported on the balance sheet. The resulting figure represents the net asset base attributable to shareholders after stripping out assets that carry significant valuation uncertainty in a distressed or liquidation context. For banks such as JPMorgan Chase and Bank of America, tangible book value per share is a primary benchmark used by analysts and management teams to assess capital adequacy and long-term value creation.
The distinction between book value and tangible book value becomes especially significant for companies that have grown through acquisitions. Each acquisition typically results in goodwill being recorded on the balance sheet — the premium paid over the fair value of the acquired assets. A company that has made large acquisitions over time may carry a book value substantially inflated by goodwill, while its tangible asset base is much smaller. Tangible book value strips away this acquisition history and focuses on assets with more verifiable economic substance.
In banking regulation, tangible common equity and tangible book value are related concepts used to assess whether a bank has sufficient loss-absorbing capital. Following the 2008 financial crisis, regulators including the Federal Reserve increased their emphasis on tangible capital metrics as part of stress testing and capital planning requirements under the Comprehensive Capital Analysis and Review (CCAR) framework.
For technology and pharmaceutical companies, tangible book value is a less meaningful anchor for valuation because the most valuable assets — software, drug patents, brand relationships, and workforce capabilities — are intangible by nature. In these sectors, earnings power and free cash flow are far more relevant than the tangible balance sheet.